Fibrate and the risk of cardiovascular disease among moderate chronic kidney disease patients with primary hypertriglyceridemia

Fibrate and the risk of cardiovascular disease among moderate chronic kidney disease patients with primary hypertriglyceridemia

IntroductionHypertriglyceridemia is the most prevalent dyslipidemia in patients with chronic kidney disease (CKD). However, research about fibrate treatment in CKD patients is limited, and assessing its benefits becomes challenging due to the frequent concurrent use of statins. Thus, this study is a...

Full description

Bibliographic Details
Main Authors: Chieh-Li Yen, Pei-Chun Fan, Cheng-Chia Lee, Jia-Jin Chen, Chao-Yu Chen, Yi-Ran Tu, Pao-Hsien Chu, Ching-Chung Hsiao, Yung-Chang Chen, Chih-Hsiang Chang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Endocrinology
Subjects:
TG
chronic kidney disease
hypertriglyceridemia
fibrate
AMI
stroke
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2024.1333553/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2024.1333553/full

Similar Items